Get started
Author

Sahar Yousefian

Evaluating the effects of Intravenous Immunoglobulin (IVIg) on the management of severe COVID-19 cases: A randomized controlled trial
2020 · Payam Tabarsi, Saghar Barati, et al. · International Immunopharmacology · 90
PDF
Subcutaneous administration of interferon beta-1a for COVID-19: A non-controlled prospective trial
2020 · Farzaneh Dastan, Seyed Alireza Nadji, et al. · International Immunopharmacology · 81
PDF
Promising effects of tocilizumab in COVID-19: A non-controlled, prospective clinical trial
2020 · Farzaneh Dastan, Ali Saffaei, et al. · International Immunopharmacology · 54
PDF
Subcutaneous tocilizumab in adults with severe and critical COVID-19: A prospective open-label uncontrolled multicenter trial
2020 · Reza Malekzadeh, Atefeh Abedini, et al. · International Immunopharmacology · 37
PDF
Evaluation of adalimumab effects in managing severe cases of COVID-19: A randomized controlled trial
2021 · Atefeh Fakharian, Saghar Barati, et al. · International Immunopharmacology · 35
PDF
Extracorporeal membrane oxygenation and COVID‐19: The causes of failure
2020 · Zargham Hossein Ahmadi, Alireza Jahangirifard, et al. · Journal of Cardiac Surgery · 31
PDF
Determination of Voriconazole Plasma Concentration by HPLC Technique and Evaluating Its Association with Clinical Outcome and Adverse Effects in Patients with Invasive Aspergillosis
2021 · Sahar Yousefian, Farzaneh Dastan, et al. · Canadian Journal of Infectious Diseases and Medical Microbiology · 17
PDF
Favipiravir Effects on the Control of Clinical Symptoms of Hospitalized COVID-19 Cases: An Experience with Iranian Formulated Dosage Form.
2021 · Payam Tabarsi, Hossein Vahidi, et al. · PubMed Central · 5
PDF
Combined Therapy of Ciclosporin Plus Favipiravir in the Management of Patients with Severe COVID-19, not Responding to Dexamethasone: A non-Controlled Prospective Trial
2021 · Saghar Barati, Seyed MohammadReza Hashemian, et al. · International Immunopharmacology · 4
PDF
The effects of combination-therapy of tocilizumab and baricitinib on the management of severe COVID-19 cases: a randomized open-label clinical trial
2023 · Farzaneh Dastan, Hamidreza Jamaati, et al. · Frontiers in Pharmacology · 3
PDF
Impact of clinical pharmacist‐led antibiotic stewardship program on clinical outcomes in a tertiary referral hospital
2021 · Payam Tabarsi, Hamidreza Jamaati, et al. · Journal of Pharmacy Practice and Research · 1
Evaluating the Effects of Nebulized Tocilizumab versus Intravenous Tocilizumab in the Management of Severe Coronavirus Disease 2019 Cases: A Randomized Clinical Trial
2023 · Farzaneh Dastan, Saghar Barati, et al. · Biomedical and Biotechnology Research Journal (BBRJ)
Evaluating the Effects of Umifenovir Compared to Lopinavir/Ritonavir in the Management of Patients with COVID-19: A Randomized Controlled Trial
2022 · Farzaneh Dastan, Jalal Heshmatnia, et al. · Microbes Infection and Chemotherapy
PDF
Successful IgM-enriched immunoglobulin treatment in severe COVID-19 pneumonia: a case report
2022 · Farzaneh Dastan, Golnaz Afzal, et al. · Microbes Infection and Chemotherapy
PDF
A Pregnant Woman with a Diagnosis of COVID-19 without Clinical Manifestations: A Case Report:
2021 · Amirhossein Lotfi, Masoud Mardani, et al. · International Pharmacy Acta
PDF
Works count: 15
Citation count: 358
H-index: 7
I10-index: 7
Year
Topic
Type